Activation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtypes by Pioglitazone
- 1 November 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 278 (3), 704-711
- https://doi.org/10.1006/bbrc.2000.3868
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Regulation of apo A-I gene expression by fibratesAtherosclerosis, 1998
- Alterations in Lipoprotein Metabolism in Peroxisome Proliferator-activated Receptor α-deficient MiceJournal of Biological Chemistry, 1997
- Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δProceedings of the National Academy of Sciences, 1997
- Pioglitazone (AD-4833) Ameliorates Insulin Resistance in Patients with NIDDMThe Tohoku Journal of Experimental Medicine, 1997
- Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.Journal of Clinical Investigation, 1996
- The Structure−Activity Relationship between Peroxisome Proliferator-Activated Receptor γ Agonism and the Antihyperglycemic Activity of ThiazolidinedionesJournal of Medicinal Chemistry, 1996
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγCell, 1995
- The RXR heterodimers and orphan receptorsCell, 1995
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)Journal of Biological Chemistry, 1995
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990